Fulvestrant, , >98% (HPLC)

Stock Code: 3573405
Manufacturer Part No: I4409-25MG

Order Now for 21 day delivery

Click Add to Quote for price and delivery

Quantity: - +

Descriptions

Application

Fulvestrant has been used:as an antagonist of estrogen receptor (ER? and ER?) to reduce hepatocytes proliferationas an antagonist of ER for the suppression of estrogen responsive element in human breast cancer MCF-7 cellsas anti-estrogen in breast cancer cell lines

Biochem/physiol Actions

Fulvestrant is a 7?-alkylsulphinyl analog of 17?-oestradiol and is structurally different compared to other selective estrogen receptor (ER) modulators (SERMs). It reduces dimerization and nuclear localization of the estrogen receptor (ER). Fulvestrant lowers the level of ER protein in human breast cancer cells. Fulvestrant is preferred for the treatment of women at their menopause having hormone-sensitive advanced breast cancer.

Fulvestrant (ICI 182,780) is a selective estrogen receptor down-regulator (SERD). Fulvestrant is a high affinity estrogen receptor antagonist. IC₅₀ = 0.29 nM. Fulvestrant is the first "pure" antiestrogen with no agonistic activity both in vitro and in vivo.

Features and Benefits

This compound was developed by AstraZeneca. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

This compound is featured on the Nuclear Receptors (Steroids) page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.

Packaging

25 mg in glass bottle

Specifications

Quality Level	100
InChI key	VWUXBMIQPBEWFH-WCCTWKNTSA-N
InChI	1S/C32H47F5O3S/c1-30-17-15-26-25-12-11-24(38)21-23(25)20-22(29(26)27(30)13-14-28(30)39)10-7-5-3-2-4-6-8-18-41(40)19-9-16-31(33,34)32(35,36)37/h11-12,21-22,26-2
Manufacturer	SIGMA-ALDRICH
Form	powder
Assay	>98% (HPLC)